Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines

Investigational New Drugs

Volumn 27, Issue 4, 2009, Pages 297-303

  Fröhlich, Eleonore ^a   Fink, Inge ^a   Wahl, Richard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Glucose metabolism; Glucose transporter; Oxythiamine; Thyroid carcinoma; Transketolase like 1

Indexed keywords

GLUCOSE TRANSPORTER 1; IODIDE; IODINE 125; OXYTHIAMINE; THYMIDINE; TRANSKETOLASE; TRANSKETOLASE LIKE 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL COUNT; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA;

ANTIMETABOLITES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IODIDES; OXYTHIAMINE; THYMIDINE; THYROID NEOPLASMS; TRANSKETOLASE;

EID: 67651174762     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9174-8     Document Type: Article

References (33)

1. F Pacini 2008 Where Do We Stand with Targeted Therapy of Refractory Thyroid Cancer?-Utility of RECIST Criteria Thyroid 18 279 280. doi:10.1089/thy.2008.0038
2. M Rivera RA Ghossein H Schoder 2008 Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma Cancer 113 1 48 56 (Pubitemid 351976385)
3. S Langbein M Zerilli A Zur Hausen 2006 Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted Br J Cancer 94 578 585. doi:10.1038/sj.bjc.6602962
4. HU Volker M Scheich B Schmausser 2007 Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas Eur Arch Otorhinolaryngol 264 1431 1436. doi:10.1007/s00405-007-0394-x
5. M Foldi E Stickeler L Bau 2007 Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer Oncol Rep 17 841 845
6. S Zhang JH Yang CK Guo 2007 Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells Cancer Lett 253 108 114. doi:10.1007/s00405-007-0394-x
7. SN Reske J Kotzerke 2001 FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000 Eur J Nucl Med 28 1707 1723
8. Nelson D, Cox M (2004) Lehninger: Principles of Biochemistry, 4th edn. Freeman, New York
9. D Singh AK Banerji BS Dwarakanath 2005 Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme Strahlenther Onkol 181 507 514. doi:10.1007/s00066-005-1320-z
10. MF Herrera ID Hay PS Wu 1992 Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior World J Surg 16 669 674. discussion 774-665 doi:10.1007/BF02067351
11. R Wahl P Brossart D Eizenberger 1992 Direct effects of protirelin (TRH) on cultured porcine thyrocytes J Endocrinol Invest 15 345 351
12. LH Hu JH Yang DT Zhang 2007 The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells Anticancer Drugs 18 427 433. doi:10.1097/CAD.0b013e328013d99e
13. M Marchesi M Biffoni F Biancari 2003 Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma Eur J Surg Suppl 588 46 50 (Pubitemid 36918757)
14. F Savagner B Franc S Guyetant 2001 Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors J Clin Endocrinol Metab 86 4920 4925. doi:10.1210/jc.86.10.4920
15. S Langbein WM Frederiks A zur Hausen 2008 Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer Int J Cancer 122 2422 2428. doi:10.1002/ijc.23403
16. A Evans V Bates H Troy 2008 Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies Cancer Chemother Pharmacol 61 377 393. doi:10.1007/s00280-007-0480-1
17. H Pelicano DS Martin RH Xu 2006 Glycolysis inhibition for anticancer treatment Oncogene 25 4633 4646. doi:10.1038/sj.onc.1209597
18. S Nagamatsu Y Nakamichi N Inoue 1996 Rat C6 glioma cell growth is related to glucose transport and metabolism Biochem J 319 Pt 2 477 482 (Pubitemid 26372206)
19. TA Smith JC Titley VR McCready 1998 Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells Nucl Med Biol 25 481 485. doi:10.1016/S0969-8051(98)00014-6
20. K Higashi AC Clavo RL Wahl 1993 Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake J Nucl Med 34 414 419 (Pubitemid 23075381)
21. P Effert AJ Beniers Y Tamimi 2004 Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma Anticancer Res 24 3057 3063 (Pubitemid 39407186)
22. S Rastogi S Banerjee S Chellappan 2007 Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines Cancer Lett 257 244 251. doi:10.1016/j.canlet.2007.07.021
23. K Yamada I Brink E Bisse 2005 Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity J Dermatol 32 316 334 (Pubitemid 40874457)
24. T Kurokawa Y Yoshida K Kawahara 2004 Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary Int J Cancer 109 926 932. doi:10.1002/ijc.20057
25. LG Boros JL Brandes FI Yusuf 1998 Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action Med Hypotheses 50 501 506. doi:10.1016/S0306-9877(98)90271-7
26. B Rais B Comin J Puigjaner 1999 Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle FEBS Lett 456 113 118. doi:10.1016/S0014-5793(99)00924-2
27. SA Strumilo SB Senkevich VV Vinogradov 1984 Effect of oxythiamine on adrenal thiamine pyrophosphate-dependent enzyme activities Biomed Biochim Acta 43 159 163 (Pubitemid 14130731)
28. M Brin 1962 Effects of thiamine deficiency and of oxythiamine on rat tissue transketolase J Nutr 78 179 183
29. JF Coy D Dressler J Wilde 2005 Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer Clin Lab (Zaragoza) 51 257 273 (Pubitemid 40895125)
30. SA Strumilo SB Senkevich EA Galitskii 1983 Enzyme activity of thiamine pyrophosphate in the rat after oxythiamine administration Biull Eksp Biol Med 96 42 44
31. Y Le Huerou I Gunawardana AA Thomas 2008 Prodrug thiamine analogs as inhibitors of the enzyme transketolase Bioorg Med Chem Lett 18 505 508. doi:10.1016/j.bmcl.2007.11.100
32. DS Shreve MP Holloway JC Haggerty 3rd 1983 The catalytic mechanism of transketolase Thiamin pyrophosphate-derived transition states for transketolase and pyruvate dehydrogenase are not identical. J Biol Chem 258 12405 12408
33. JF Coy S Dubel P Kioschis 1996 Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes Genomics 32 309 316. doi:10.1006/geno.1996.0124